MACKENZIE FINANCIAL CORP - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 140 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACKENZIE FINANCIAL CORP ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$91,656
+6.9%
21,119
-24.9%
0.00%
Q2 2023$85,723
+119.4%
28,1060.0%0.00%
Q1 2023$39,067
-30.2%
28,1060.0%0.00%
Q4 2022$55,931
-91.0%
28,106
-84.2%
0.00%
-100.0%
Q1 2020$619,000177,8780.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$83,503,0007.34%
Eversept Partners, LP 2,656,208$10,306,0872.29%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$62,908,0001.13%
Prosight Management, LP 512,659$1,989,0000.95%
THB ASSET MANAGEMENT 833,104$3,232,0000.90%
GLOBEFLEX CAPITAL L P 251,696$977,0000.26%
XTX MARKETS LLC 10,243$40,0000.19%
HUSSMAN STRATEGIC ADVISORS, INC. 102,000$396,0000.10%
PA Capital LLC 33,874$132,0000.09%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 60,900$236,0000.07%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders